The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug ...

Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

including a generic version of Symbicort and one other undisclosed inhalation product. Symbicort is an asthma and COPD medication with over $3 billion in annual sales, presenting a major market ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...

Flovent HFA, GSK’s brand name for its discontinued inhaler ... to cover a prescription for Symbicort as a Flovent replacement. In 2024, though, that drug was no longer included in the insurer ...